Niox Group (NIOX)

Sector:

Health Care

Index:

FTSE AIM 50

69.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 76.00
  • 52 Week Low: 54.60
  • Currency: UK Pounds
  • Shares Issued: 417.78m
  • Volume: 4,108
  • Market Cap: £288.27m

Niox Group Overview

Niox Group is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.

Key Personnel

CEO: Jonathan Emms
Independent Non-Executive Director: Sharon Curran
Independent Non-Executive Director: Jo Le Couilliard
Non-Executive Chairman: Ian Johnson
Senior Independent Director: Garry Watts
Non-Executive Dir: Nicholas Mills, Robert (Rob) Graham Naylor

Contact Details

Address: Hayakawa Building, Edmund Halley Road, Oxford Science Park, Oxford, United Kingdom, OX4 4GB
Phone: +44 (0)1865 405560
Fax: +44 (0)7092 987560
Website: http://www.niox.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
Overseas Listings: BATSLON:CIRL
ISIN: GB00BJVD3B28

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Niox Group Market Data

Currency UK Pounds
Share Price 69.00p
Change Today -1.00p
% Change -1.43 %
52 Week High 76.00
52 Week Low 54.60
Volume 4,108
Shares Issued 417.78m
Market Cap £288.27m

Niox Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.09% below the market average90.09% below the market average90.09% below the market average90.09% below the market average90.09% below the market average
51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average
Price Trend
18.47% above the market average18.47% above the market average18.47% above the market average18.47% above the market average18.47% above the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average
Income
80.56% below the market average80.56% below the market average80.56% below the market average80.56% below the market average80.56% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Growth
45.20% above the market average45.20% above the market average45.20% above the market average45.20% above the market average45.20% above the market average
2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Niox Group Dividends

  Latest Previous
  Final Final
Ex-Div 15-May-25 23-May-24
Paid 16-Jun-25 24-Jun-24
Amount 1.25p 1.00p

Trades for 04-Aug-2025

Time Volume / Share Price
11:14 57 @ 69.93p
10:59 1 @ 70.40p
10:00 516 @ 69.98p
09:31 4 @ 70.40p
09:28 993 @ 69.93p

Niox Group Key Personnel

CEO Jonathan Emms

Top of Page